市場調査レポート

商品コード

1424031

単純ヘルペスウイルス治療市場、シェア、規模、動向、産業分析レポート：タイプ別、薬剤別、ワクチン別、投与経路別、最終用途別、地域別、セグメント予測、2024年～2032年

Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032

出版日: 2024年01月24日 | 発行: Polaris Market Research

| ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 666,230円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 822,990円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 979,750円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界の単純ヘルペスウイルス治療市場規模は2032年までに46億6,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ウイルスの感染力が高いため、政府機関や人々はできるだけ早く治療を受ける必要に迫られています。単純ヘルペスは、ヒトの感染率に基づいて2つのタイプに分けられるウイルスです。HSV-1は通常、感染者からの皮膚接触によって感染します。一方、HSV-2は口唇ヘルペスで、感染者の唾液に性行為以外で接触することで、主に小児期に感染します。単純ヘルペスウイルスの効率的な治療が必要な大きな要因の1つは、人が一度感染すると一生続く可能性があることです。

単純ヘルペスウイルスは人体内に入ると潜伏ネットワークを構築します。1週間から10日ほどで消失しますが、鼻や口の周りの皮膚に痛みを伴う水疱ができることがあります。場合によっては、単純ヘルペスが有害な脳炎や眼感染症を引き起こすこともあります。世界保健機関（WHO）によると、単純ヘルペスウイルスは社会でより一般的な病気であり、世界人口の約3分の2が罹患しています。このことは、世界市場における単純ヘルペスウイルス治療の本質を強調しています。

単純ヘルペスウイルス治療を治す可能性のある新しい治療法を革新するための研究開発活動の高まりは、市場に大きな成長機会を示すと期待されています。例えば、Nature Communicationsに掲載された2023年の研究では、細胞景観と単純ヘルペスウイルス1型の関係が探求され、両者が関連していることが明らかになった。これらの調査研究は、予測期間中に単純ヘルペスウイルス治療の進歩を促進すると予想されます。

さらに、単純ヘルペスウイルスの治療のための革新的なワクチンへの投資の高まりは、市場の成長を著しく促進しています。例えば、Shenzhen Mellow Hope Pharm Industrial社とRational Vaccines社は、中国でヘルペスワクチンを開発するために戦略的提携を結びました。

単純ヘルペスウイルス治療市場レポートハイライト

単純ヘルペスウイルス-1（HSV-1）セグメントは、感染率が高いため、今後数年間で最も高い成長が見込まれます。

バラシクロビルセグメントは、治療薬の吸収率が高い可能性があることから、最大の市場シェアを占めています。

アジア太平洋地域は、感染者との接触リスクを背景に、予測期間中に最も速い成長を記録すると予測されます。

単純ヘルペスウイルス治療- 業界スナップショット
単純ヘルペスウイルス治療市場力学
- 促進要因と機会
  - 世界の感染率上昇
  - 細胞治療および遺伝子治療を探求する研究の増加が市場の成長を推進
- 抑制要因と課題
  - 規制上のハードルが市場の成長を妨げる可能性がある
PESTLE分析
単純ヘルペスウイルス治療業界の動向
COVID-19感染症の影響分析

第5章世界の単純ヘルペスウイルス治療市場、タイプ別

主な調査結果
イントロダクション
単純ヘルペスウイルス-1（HSV-1）
単純ヘルペスウイルス-2（HSV-2）

第6章世界の単純ヘルペスウイルス治療市場、薬剤別

主な調査結果
イントロダクション
アシクロビル
バラシクロビル
ファムシクロビル
その他の薬物

第7章世界の単純ヘルペスウイルス治療市場、ワクチン別

主な調査結果
イントロダクション
シンプリリクス
その他

第8章世界の単純ヘルペスウイルス治療市場、投与経路別

主な調査結果
イントロダクション
経口
注射
局所

第9章世界の単純ヘルペスウイルス治療市場、最終用途別

主な調査結果
イントロダクション
病院薬局
小売薬局
オンライン薬局

第10章世界の単純ヘルペスウイルス治療市場、地域別

主な調査結果
イントロダクション
- 単純ヘルペスウイルス治療市場評価、地域別、2019年～2032年
単純ヘルペスウイルス治療市場 - 北米
- 北米：単純ヘルペスウイルス治療市場、タイプ別、2019年～2032年
- 北米：単純ヘルペスウイルス治療市場、投与経路別、2019年～2032年
- 北米：単純ヘルペスウイルス治療市場、薬剤別、2019年～2032年
- 北米：単純ヘルペスウイルス治療市場、ワクチン別、2019年～2032年
- 北米：単純ヘルペスウイルス治療市場、最終用途別、2019年～2032年
- 単純ヘルペスウイルス治療市場 - 米国
- 単純ヘルペスウイルス治療市場 - カナダ
単純ヘルペスウイルス治療市場 - 欧州
- 欧州：単純ヘルペスウイルス治療市場、タイプ別、2019年～2032年
- 欧州：単純ヘルペスウイルス治療市場、投与経路別、2019年～2032年
- 欧州：単純ヘルペスウイルス治療市場、薬剤別、2019年～2032年
- 欧州：単純ヘルペスウイルス治療市場、ワクチン別、2019年～2032年
- 欧州：単純ヘルペスウイルス治療市場、最終用途別、2019年～2032年
- 単純ヘルペスウイルス治療市場 - 英国
- 単純ヘルペスウイルス治療市場 - フランス
- 単純ヘルペスウイルス治療市場 - ドイツ
- 単純ヘルペスウイルス治療市場 - イタリア
- 単純ヘルペスウイルス治療市場 - スペイン
- 単純ヘルペスウイルス治療市場 - オランダ
- 単純ヘルペスウイルス治療市場 - ロシア
単純ヘルペスウイルス治療市場 - アジア太平洋
- アジア太平洋：単純ヘルペスウイルス治療市場、タイプ別、2019年～2032年
- アジア太平洋：単純ヘルペスウイルス治療市場、投与経路別、2019年～2032年
- アジア太平洋：単純ヘルペスウイルス治療市場、薬剤別、2019年～2032年
- アジア太平洋：単純ヘルペスウイルス治療市場、ワクチン別、2019年～2032年
- アジア太平洋：単純ヘルペスウイルス治療市場、最終用途別、2019年～2032年
- 単純ヘルペスウイルス治療市場 - 中国
- 単純ヘルペスウイルス治療市場 - インド
- 単純ヘルペスウイルス治療市場 - 日本
- 単純ヘルペスウイルス治療市場 - マレーシア
- 単純ヘルペスウイルス治療市場 - インドネシア
- 単純ヘルペスウイルス治療市場 - 韓国
単純ヘルペスウイルス治療市場 - 中東・アフリカ
- 中東・アフリカ：単純ヘルペスウイルス治療市場、タイプ別、2019年～2032年
- 中東・アフリカ：単純ヘルペスウイルス治療市場、投与経路別、2019年～2032年
- 中東・アフリカ：単純ヘルペスウイルス治療市場、薬剤別、2019年～2032年
- 中東・アフリカ：単純ヘルペスウイルス治療市場、ワクチン別、2019年～2032年
- 中東・アフリカ：単純ヘルペスウイルス治療市場、最終用途別、2019年～2032年
- 単純ヘルペスウイルス治療市場 - サウジアラビア
- 単純ヘルペスウイルス治療市場 - アラブ首長国連邦
- 単純ヘルペスウイルス治療市場 - イスラエル
- 単純ヘルペスウイルス治療市場 - 南アフリカ
単純ヘルペスウイルス治療市場 - ラテンアメリカ
- ラテンアメリカ：単純ヘルペスウイルス治療市場、タイプ別、2019年～2032年
- ラテンアメリカ：単純ヘルペスウイルス治療市場、投与経路別、2019年～2032年
- ラテンアメリカ：単純ヘルペスウイルス治療市場、薬剤別、2019年～2032年
- ラテンアメリカ：単純ヘルペスウイルス治療市場、ワクチン別、2019年～2032年
- ラテンアメリカ：単純ヘルペスウイルス治療市場、最終用途別、2019年～2032年
- 単純ヘルペスウイルス治療市場 - メキシコ
- 単純ヘルペスウイルス治療市場 - ブラジル
- 単純ヘルペスウイルス治療市場 - アルゼンチン

第11章競合情勢

拡張と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第12章企業プロファイル

Apotex Inc.
Carlsbad Tech
Emcure Pharmaceuticals Ltd.
Fresenius Kabi AG
GSK plc
Glenmark Pharmaceuticals Inc.
Novartis AG
Sanofi
Teva Pharmaceuticals Industries Ltd.
Viatris, Inc.

図表

List of Tables

Table 1 Global Herpes Simplex Virus Treatment Market, by Type, by Region, 2019-2032 (USD Billion)
Table 2 Global Herpes Simplex Virus Treatment Market, by Drug, by Region, 2019-2032 (USD Billion)
Table 3 Global Herpes Simplex Virus Treatment Market, by Vaccine, by Region, 2019-2032 (USD Billion)
Table 4 Global Herpes Simplex Virus Treatment Market, by End Use, by Region, 2019-2032 (USD Billion)
Table 5 Global Herpes Simplex Virus Treatment Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
Table 6 North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 7 North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 8 North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 9 North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 10 North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 11 U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 12 U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 13 U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 14 U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 15 U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 16 Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 17 Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 18 Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 19 Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 20 Canada: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 21 Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 22 Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 23 Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 24 Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 25 Europe: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 26 Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 27 Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 28 Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 29 Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 30 Germany: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 31 France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 32 France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 33 France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 34 France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 35 France: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 36 UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 37 UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 38 UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 39 UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 40 UK: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 41 Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 42 Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 43 Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 44 Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 45 Italy: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 46 Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 47 Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 48 Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 49 Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 50 Netherlands: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 51 Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 52 Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 53 Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 54 Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 55 Spain: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 56 Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 57 Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 58 Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 59 Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 60 Russia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 61 Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 62 Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 63 Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 64 Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 65 Asia Pacific: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 66 China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 67 China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 68 China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 69 China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 70 China: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 71 Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 72 Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 73 Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 74 Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 75 Japan: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 76 India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 77 India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 78 India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 79 India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 80 India: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 81 Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 82 Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 83 Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 84 Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 85 Indonesia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 86 Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 87 Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 88 Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 89 Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 90 Malaysia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 91 South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 92 South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 93 South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 94 South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 95 South Korea: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 96 Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 97 Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 98 Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 99 Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 100 Latin America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 101 Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 102 Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 103 Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 104 Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 105 Brazil: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 106 Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 107 Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 108 Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 109 Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 110 Mexico: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 111 Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 112 Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 113 Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 114 Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 115 Argentina: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 116 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 117 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 118 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 119 Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 120 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 121 UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 122 UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 123 UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 124 UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 125 UAE: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 126 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 127 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 128 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 129 Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 130 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 131 South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 132 South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 133 South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 134 South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 135 South Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
Table 136 Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
Table 137 Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
Table 138 Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
Table 139 Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
Table 140 Israel: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Herpes Simplex Virus Treatment Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Herpes Simplex Virus Treatment Market, by Type, 2021 & 2030 (USD Billion)
Figure 8. Market by Drug
Figure 9. Global Herpes Simplex Virus Treatment Market, by Drug, 2021 & 2030 (USD Billion)
Figure 10. Market by Vaccine
Figure 11. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2021 & 2030 (USD Billion)
Figure 12. Market by End Use
Figure 13. Global Herpes Simplex Virus Treatment Market, by End Use, 2021 & 2030 (USD Billion)
Figure 14. Market by Route of Administration
Figure 15. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2021 & 2030 (USD Billion)

Product Code: PM4333

The global herpes simplex virus treatment market size is expected to reach USD 4.66 billion by 2032, according to a new study by Polaris Market Research. The report "Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The higher transmission potential of viruses is forcing government agencies and people to get treatment as quickly as possible. Herpes simplex is a virus that is divided into two types based on the infection rate among humans. HSV-1 is usually transmitted through skin-to-skin contact from the infected person. At the same time, HSV-2 is an oral herpes that mostly infects children during childhood due to non-sexual contact with the saliva of infected people. One of the major factors driving the need for efficient treatment of the herpes simplex virus is that if a person gets infected once, then it can last forever.

The herpes simplex virus builds a latent network once it gets inside the human body. While it is likely to vanish after a week to ten days, it can cause painful blisters on the skin around the nose and mouth. In some cases, herpes simplex may lead to harmful brain inflammation and eye infections. According to the World Health Organization, the herpes simplex virus is a more common disease in society, affecting about two-thirds of the world population. This is emphasizing the essence of herpes simplex virus treatment in the global market.

The growing research and development activities to innovate new therapies with the potential to cure herpes simplex virus treatment are expected to showcase significant growth opportunities in the market. For instance, a 2023 study published in Nature Communications explored the relationship between the cellular landscape and herpes simplex virus type 1 and revealed that both are connected. These research studies are expected to drive advancements in herpes simplex virus treatment during the forecast period.

Moreover, rising investments in innovative vaccines for the treatment of the herpes simplex virus are significantly driving market growth. For instance, Shenzhen Mellow Hope Pharm Industrial. & Rational Vaccines entered into a strategic collaboration to develop herpes vaccines in China.

Herpes Simplex Virus Treatment Market Report Highlights

The Herpes Simplex Virus-1 (HSV-1) segment is anticipated to witness the highest growth in the coming years due to the higher rate of transmission.

Valacyclovir segment accounted for the largest market share owing to the potential for a higher absorption rate of treatment.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the risk of contact with infected persons.

The global players include Apotex Inc., Carlsbad Tech, Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, GSK plc, Glenmark Pharmaceuticals Inc., & Novartis AG.

Polaris Market Research has segmented the herpes simplex virus treatment market report based on type, drug, vaccine, route of administration, end-use, and region:

Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus-1 (HSV-1)
Herpes simplex virus-2 (HSV-2)

Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

Acyclovir
Valacyclovir
Famciclovir
Other Drugs

Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)

Simplirix
Others

Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Oral
Injectable
Topical

Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Herpes Simplex Virus Treatment Market Insights

4.1. Herpes Simplex Virus Treatment - Industry Snapshot
4.2. Herpes Simplex Virus Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. The rising infection rate in the world
  - 4.2.1.2. The rising studies exploring cell and gene therapies are driving the market growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory hurdles are likely to impede market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Herpes Simplex Virus Treatment Industry Trends
4.6. COVID-19 Impact Analysis

5. Global Herpes Simplex Virus Treatment Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
5.3. Herpes Simplex Virus-1 (HSV-1)
- 5.3.1. Global Herpes Simplex Virus Treatment Market, by Herpes Simplex Virus-1 (HSV-1), by Region, 2019-2032 (USD Billion)
5.4. Herpes simplex virus-2 (HSV-2)
- 5.4.1. Global Herpes Simplex Virus Treatment Market, by Herpes simplex virus-2 (HSV-2), by Region, 2019-2032 (USD Billion)

6. Global Herpes Simplex Virus Treatment Market, by Drug

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
6.3. Acyclovir
- 6.3.1. Global Herpes Simplex Virus Treatment Market, by Acyclovir, by Region, 2019-2032 (USD Billion)
6.4. Valacyclovir
- 6.4.1. Global Herpes Simplex Virus Treatment Market, by Valacyclovir, by Region, 2019-2032 (USD Billion)
6.5. Famciclovir
- 6.5.1. Global Herpes Simplex Virus Treatment Market, by Famciclovir, by Region, 2019-2032 (USD Billion)
6.6. Other Drugs
- 6.6.1. Global Herpes Simplex Virus Treatment Market, by Other Drugs, by Region, 2019-2032 (USD Billion)

7. Global Herpes Simplex Virus Treatment Market, by Vaccine

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
7.3. Simplirix
- 7.3.1. Global Herpes Simplex Virus Treatment Market, by Simplirix, by Region, 2019-2032 (USD Billion)
7.4. Others
- 7.4.1. Global Herpes Simplex Virus Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Herpes Simplex Virus Treatment Market, by Route of Administration

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
8.3. Oral
- 8.3.1. Global Herpes Simplex Virus Treatment Market, by Oral, by Region, 2019-2032 (USD Billion)
8.4. Injectable
- 8.4.1. Global Herpes Simplex Virus Treatment Market, by Injectable, by Region, 2019-2032 (USD Billion)
8.5. Topical
- 8.5.1. Global Herpes Simplex Virus Treatment Market, by Topical, by Region, 2019-2032 (USD Billion)

9. Global Herpes Simplex Virus Treatment Market, by End Use

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
9.3. Hospital Pharmacy
- 9.3.1. Global Herpes Simplex Virus Treatment Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
9.4. Retail Pharmacy
- 9.4.1. Global Herpes Simplex Virus Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
9.5. Online Pharmacy
- 9.5.1. Global Herpes Simplex Virus Treatment Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)

10. Global Herpes Simplex Virus Treatment Market, by Geography

10.1. Key findings
10.2. Introduction
- 10.2.1. Herpes Simplex Virus Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
10.3. Herpes Simplex Virus Treatment Market - North America
- 10.3.1. North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
- 10.3.2. North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.3.3. North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
- 10.3.4. North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
- 10.3.5. North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.3.6. Herpes Simplex Virus Treatment Market - U.S.
  - 10.3.6.1. U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.3.6.2. U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.3.6.3. U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.3.6.4. U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.3.6.5. U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.3.7. Herpes Simplex Virus Treatment Market - Canada
  - 10.3.7.1. Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.3.7.2. Canada.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.3.7.3. Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.3.7.4. Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.3.7.5. Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4. Herpes Simplex Virus Treatment Market - Europe
- 10.4.1. Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
- 10.4.2. Europe.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.4.3. Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
- 10.4.4. Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
- 10.4.5. Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.6. Herpes Simplex Virus Treatment Market - UK
  - 10.4.6.1. UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.6.2. UK.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.6.3. UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.6.4. UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.6.5. UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.7. Herpes Simplex Virus Treatment Market - France
  - 10.4.7.1. France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.7.2. France.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.7.3. France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.7.4. France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.7.5. France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.8. Herpes Simplex Virus Treatment Market - Germany
  - 10.4.8.1. Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.8.2. Germany.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.8.3. Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.8.4. Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.8.5. Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.9. Herpes Simplex Virus Treatment Market - Italy
  - 10.4.9.1. Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.9.2. Italy.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.9.3. Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.9.4. Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.9.5. Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.10. Herpes Simplex Virus Treatment Market - Spain
  - 10.4.10.1. Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.10.2. Spain.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.10.3. Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.10.4. Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.10.5. Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.11. Herpes Simplex Virus Treatment Market - Netherlands
  - 10.4.11.1. Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.11.2. Netherlands.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.11.3. Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.11.4. Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.11.5. Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.4.12. Herpes Simplex Virus Treatment Market - Russia
  - 10.4.12.1. Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.4.12.2. Russia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.12.3. Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.4.12.4. Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.4.12.5. Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5. Herpes Simplex Virus Treatment Market - Asia Pacific
- 10.5.1. Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
- 10.5.2. Asia Pacific.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.5.3. Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
- 10.5.4. Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
- 10.5.5. Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.6. Herpes Simplex Virus Treatment Market - China
  - 10.5.6.1. China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.6.2. China.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.6.3. China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.6.4. China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.6.5. China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.7. Herpes Simplex Virus Treatment Market - India
  - 10.5.7.1. India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.7.2. India.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.7.3. India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.7.4. India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.7.5. India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.8. Herpes Simplex Virus Treatment Market - Japan
  - 10.5.8.1. Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.8.2. Japan.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.8.3. Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.8.4. Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.8.5. Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.9. Herpes Simplex Virus Treatment Market - Malaysia
  - 10.5.9.1. Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.9.2. Malaysia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.9.3. Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.9.4. Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.9.5. Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.10. Herpes Simplex Virus Treatment Market - Indonesia
  - 10.5.10.1. Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.10.2. Indonesia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.10.3. Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.10.4. Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.10.5. Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.5.11. Herpes Simplex Virus Treatment Market - South Korea
  - 10.5.11.1. South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.5.11.2. South Korea.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.11.3. South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.5.11.4. South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.5.11.5. South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6. Herpes Simplex Virus Treatment Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
- 10.6.2. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.6.3. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
- 10.6.4. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
- 10.6.5. Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.6.6. Herpes Simplex Virus Treatment Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.6.6.2. Saudi Arabia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.6.7. Herpes Simplex Virus Treatment Market - UAE
  - 10.6.7.1. UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.6.7.2. UAE.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.7.3. UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.6.7.4. UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.6.7.5. UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.6.8. Herpes Simplex Virus Treatment Market - Israel
  - 10.6.8.1. Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.6.8.2. Israel.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.8.3. Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.6.8.4. Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.6.8.5. Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.6.9. Herpes Simplex Virus Treatment Market - South Africa
  - 10.6.9.1. South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.6.9.2. South Africa.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.9.3. South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.6.9.4. South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.6.9.5. South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.7. Herpes Simplex Virus Treatment Market - Latin America
- 10.7.1. Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
- 10.7.2. Latin America.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.7.3. Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
- 10.7.4. Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
- 10.7.5. Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.7.6. Herpes Simplex Virus Treatment Market - Mexico
  - 10.7.6.1. Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.7.6.2. Mexico.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.6.3. Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.7.6.4. Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.7.6.5. Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.7.7. Herpes Simplex Virus Treatment Market - Brazil
  - 10.7.7.1. Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.7.7.2. Brazil.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.7.3. Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.7.7.4. Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.7.7.5. Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
- 10.7.8. Herpes Simplex Virus Treatment Market - Argentina
  - 10.7.8.1. Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  - 10.7.8.2. Argentina.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.8.3. Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  - 10.7.8.4. Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  - 10.7.8.5. Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Apotex Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Carlsbad Tech
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Emcure Pharmaceuticals Ltd.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Fresenius Kabi AG
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. GSK plc
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Glenmark Pharmaceuticals Inc.
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Novartis AG
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Sanofi
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Teva Pharmaceuticals Industries Ltd.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Viatris, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development

単純ヘルペスウイルス治療市場、シェア、規模、動向、産業分析レポート：タイプ別、薬剤別、ワクチン別、投与経路別、最終用途別、地域別、セグメント予測、2024年～2032年

Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032

単純ヘルペスウイルス治療市場レポートハイライト

目次

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の単純ヘルペスウイルス治療市場の洞察

第5章世界の単純ヘルペスウイルス治療市場、タイプ別

第6章世界の単純ヘルペスウイルス治療市場、薬剤別

第7章世界の単純ヘルペスウイルス治療市場、ワクチン別

第8章世界の単純ヘルペスウイルス治療市場、投与経路別

第9章世界の単純ヘルペスウイルス治療市場、最終用途別

第10章世界の単純ヘルペスウイルス治療市場、地域別

第11章競合情勢

第12章企業プロファイル

List of Tables

List of Figures

Herpes Simplex Virus Treatment Market Report Highlights

Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

2. Executive Summary

3. Research Methodology

4. Global Herpes Simplex Virus Treatment Market Insights

5. Global Herpes Simplex Virus Treatment Market, by Type

6. Global Herpes Simplex Virus Treatment Market, by Drug

7. Global Herpes Simplex Virus Treatment Market, by Vaccine

8. Global Herpes Simplex Virus Treatment Market, by Route of Administration

9. Global Herpes Simplex Virus Treatment Market, by End Use

10. Global Herpes Simplex Virus Treatment Market, by Geography

11. Competitive Landscape

12. Company Profiles

単純ヘルペスウイルス治療市場、シェア、規模、動向、産業分析レポート：タイプ別、薬剤別、ワクチン別、投与経路別、最終用途別、地域別、セグメント予測、2024年～2032年

Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032

単純ヘルペスウイルス治療市場レポートハイライト

目次

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の単純ヘルペスウイルス治療市場の洞察

第5章 世界の単純ヘルペスウイルス治療市場、タイプ別

第6章 世界の単純ヘルペスウイルス治療市場、薬剤別

第7章 世界の単純ヘルペスウイルス治療市場、ワクチン別

第8章 世界の単純ヘルペスウイルス治療市場、投与経路別

第9章 世界の単純ヘルペスウイルス治療市場、最終用途別

第10章 世界の単純ヘルペスウイルス治療市場、地域別

第11章 競合情勢

第12章 企業プロファイル

List of Tables

List of Figures

Herpes Simplex Virus Treatment Market Report Highlights

Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

2. Executive Summary

3. Research Methodology

4. Global Herpes Simplex Virus Treatment Market Insights

5. Global Herpes Simplex Virus Treatment Market, by Type

6. Global Herpes Simplex Virus Treatment Market, by Drug

7. Global Herpes Simplex Virus Treatment Market, by Vaccine

8. Global Herpes Simplex Virus Treatment Market, by Route of Administration

9. Global Herpes Simplex Virus Treatment Market, by End Use

10. Global Herpes Simplex Virus Treatment Market, by Geography

11. Competitive Landscape

12. Company Profiles

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の単純ヘルペスウイルス治療市場の洞察

第5章世界の単純ヘルペスウイルス治療市場、タイプ別

第6章世界の単純ヘルペスウイルス治療市場、薬剤別

第7章世界の単純ヘルペスウイルス治療市場、ワクチン別

第8章世界の単純ヘルペスウイルス治療市場、投与経路別

第9章世界の単純ヘルペスウイルス治療市場、最終用途別

第10章世界の単純ヘルペスウイルス治療市場、地域別

第11章競合情勢

第12章企業プロファイル